Filing Details

Accession Number:
0001104659-19-002152
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-16 19:10:11
Reporting Period:
2019-01-14
Accepted Time:
2019-01-16 19:10:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1297184 Amphastar Pharmaceuticals Inc. AMPH Pharmaceutical Preparations (2834) 330702205
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1743927 Yakob Liawatidewi C/O Amphastar Pharmaceuticals, Inc.
11570 6Th Street
Rancho Cucamonga CA 91730
Svp Corp Admin Center No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-01-14 8 $10.48 37,471 No 4 M Direct
Common Stock Disposition 2019-01-14 8 $22.15 37,463 No 4 S Direct
Common Stock Acquisiton 2019-01-16 3,175 $10.48 40,638 No 4 M Direct
Common Stock Disposition 2019-01-16 3,175 $22.15 37,463 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2019-01-14 8 $0.00 8 $10.48
Common Stock Stock Option (right to buy) Disposition 2019-01-16 3,175 $0.00 3,175 $10.48
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
19,992 2022-11-07 No 4 M Direct
16,817 2022-11-07 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 6,369 Indirect See footnote
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2018.
  2. The reported shares are held of record by the Yakob and Sunmoon Trust dated July 25, 2013 for which the reporting person serves as a trustee.
  3. Shares subject to the option are fully vested and immediately exercisable.